Christopher Barker

Dr. Christopher Barker

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2009 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
CBChristopher Barker
Christopher Barker
CIChristopher Illies
Christopher Illies
GGGian Carlo Gaboardi
Gian Carlo Gaboardi
PBPer-Olof Berggren
Per-Olof Berggren

1 June 2018 in Cellular Signalling
Verified
Journal Article
Open access
SRSubu Surendran Rajasekaran
Subu Surendran Rajasekaran
JKJaeyoon Kim
Jaeyoon Kim
GGGian-Carlo Gaboardi
Gian-Carlo Gaboardi
JGJesper Gromada
Jesper Gromada
Sthephen ShearsSthephen Shears
Sthephen Shears
PBPer-Olof Berggren
Per-Olof Berggren
Diphosphoinositol pentakisphosphate (IP7) is critical for the exocytotic capacity of the pancreatic β-cell, but its regulation by the primary instigator of β-cell exocytosis, glucose, is unknown. The high Km for ATP of the IP7-generating enzymes, the inositol hexakisphosphate kinases (IP6K1 and 2) suggests that these enzymes might serve as metabolic sensors in insulin secreting β-cells and act as translators of disrupted metabolism in diabetes. We investigated this hypothesis and now show that glucose stimulation, which increases the ATP/ADP ratio, leads to an early rise in IP7 concentration in β-cells. RNAi mediated knock down of the IP6K1 isoform inhibits both glucose-mediated increase in IP7 and first phase insulin secretion, demonstrating that IP6K1 integrates glucose metabolism and insulin exocytosis. In diabetic mouse islets the deranged ATP/ADP levels under both basal and glucose-stimulated conditions are mirrored in both disrupted IP7 generation and insulin release. Thus the unique metabolic sensing properties of IP6K1 guarantees appropriate concentrations of IP7 and thereby both correct basal insulin secretion and intact first phase insulin release. In addition, our data suggest that a specific cell signaling defect, namely, inappropriate IP7 generation may be an essential convergence point integrating multiple metabolic defects into the commonly observed phenotype in diabetes.

24 May 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
JYJia Yu
Jia Yu
BLBarbara Leibiger
Barbara Leibiger
SYShao-Nian Yang
Shao-Nian Yang
Sthephen ShearsSthephen Shears
Sthephen Shears
ILIngo B. Leibiger
Ingo B. Leibiger
CBChristopher Barker
Christopher Barker
Multiple inositol polyphosphate phosphatase (MINPP1) is an enigmatic enzyme that is responsible for the metabolism of inositol hexakisphosphate (InsP6) and inositol 1,3,4,5,6 pentakisphosphate (Ins(1,3,4,5,6)P5 in mammalian cells, despite being restricted to the confines of the ER. The reason for this compartmentalization is unclear. In our previous studies in the insulin-secreting HIT cell line, we expressed MINPP1 in the cytosol to artificially reduce the concentration of these higher inositol phosphates. Undocumented at the time, we noted cytosolic MINPP1 expression reduced cell growth. We were struck by the similarities in substrate preference between a number of different enzymes that are able to metabolize both inositol phosphates and lipids, notably IPMK and PTEN. MINPP1 was first characterized as a phosphatase that could remove the 3-phosphate from inositol 1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P4). This molecule shares strong structural homology with the major product of the growth-promoting Phosphatidyl 3-kinase (PI3K), phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) and PTEN can degrade both this lipid and Ins(1,3,4,5)P4. Because of this similar substrate preference, we postulated that the cytosolic version of MINPP1 (cyt-MINPP1) may not only attack inositol polyphosphates but also PtdIns(3,4,5)P3, a key signal in mitogenesis. Our experiments show that expression of cyt-MINPP1 in HIT cells lowers the concentration of PtdIns(3,4,5)P3. We conclude this reflects a direct effect of MINPP1 upon the lipid because cyt-MINPP1 actively dephosphorylates synthetic, di(C4:0)PtdIns(3,4,5)P3 in vitro. These data illustrate the importance of MINPP1′s confinement to the ER whereby important aspects of inositol phosphate metabolism and inositol lipid signaling can be separately regulated and give one important clarification for MINPP1′s ER seclusion.

23 March 2010
Verified
Book Chapter
Closed access
PDF file
ANAndreas Nagel
Andreas Nagel
CBChristopher Barker
Christopher Barker
PBPer-Olof Berggren
Per-Olof Berggren
CIChristopher Illies
Christopher Illies

21 August 2020 in Diabetes
Verified
Journal Article
Closed access
PDF file
CBChristopher Barker
Christopher Barker
FTFernando Henrique Galvão Tessaro
Fernando Henrique Galvão Tessaro
SFSabrina de Souza Ferreira
Sabrina de Souza Ferreira
RSRafael Simas
Rafael Simas
TAThais S. Ayala
Thais S. Ayala
PBPer-Olof Berggren
Per-Olof Berggren
Glucose-stimulated insulin secretion is the hallmark of the pancreatic β-cell, a critical player in the regulation of blood glucose concentration. In 1974, the remarkable observation was made that an efflux of intracellular inorganic phosphate (Pi) accompanied the events of stimulated insulin secretion. The mechanism behind this “phosphate flush,” its association with insulin secretion, and its regulation have since then remained a mystery. We recapitulated the phosphate flush in the MIN6m9 β-cell line and pseudoislets. We demonstrated that knockdown of XPR1, a phosphate transporter present in MIN6m9 cells and pancreatic islets, prevented this flush. Concomitantly, XPR1 silencing led to intracellular Pi accumulation and a potential impact on Ca2+ signaling. XPR1 knockdown slightly blunted first-phase glucose-stimulated insulin secretion in MIN6m9 cells, but had no significant impact on pseudoislet secretion. In keeping with other cell types, basal Pi efflux was stimulated by inositol pyrophosphates, and basal intracellular Pi accumulated following knockdown of inositol hexakisphosphate kinases. However, the glucose-driven phosphate flush occurred despite inositol pyrophosphate depletion. Finally, while it is unlikely that XPR1 directly affects exocytosis, it may protect Ca2+ signaling. Thus, we have revealed XPR1 as the missing mediator of the phosphate flush, shedding light on a 45-year-old mystery.

31 December 2009 in Advances in Enzyme Regulation
Verified
Journal Article
Closed access
CBChristopher Barker
Christopher Barker
CIChristopher Illies
Christopher Illies
RFRoberta Fiume
Roberta Fiume
GGGian Carlo Gaboardi
Gian Carlo Gaboardi
JYJia Yu
Jia Yu
PBPer-Olof Berggren
Per-Olof Berggren